Aptevo Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aptevo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aptevo Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aptevo Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1 | 5 | 0.20 |
| 2023-09-30 | $27 | 85 | 0.33 |
| 2022-12-31 | $3.3k | 1.4k | 2.32 |
| 2022-09-30 | $1.0k | 430 | 2.33 |
| 2022-06-30 | $4.0k | 1.1k | 3.61 |
| 2021-12-31 | $25k | 3.2k | 7.78 |
| 2021-06-30 | $41k | 1.8k | 22.52 |
| 2020-12-31 | $11k | 311 | 35.37 |
| 2020-09-30 | $67k | 8.8k | 7.57 |
| 2020-06-30 | $83k | 10k | 8.32 |
| 2020-03-31 | $43k | 12k | 3.72 |